We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

FF:NYSEFutureFuel Corp. Analysis

Data as of 2026-04-02 - not real-time

$4.18

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

FutureFuel Corp. trades at $4.18, just above its 20‑day SMA of 3.95 and comfortably above the 50‑day (3.89) and 200‑day (3.78) averages, indicating a short‑term bullish bias. Technical momentum is reinforced by a bullish MACD histogram (+0.029) and a neutral‑to‑slightly‑overbought RSI of 57, while the stock sits near the upper end of its support zone at 3.12 and below the resistance level of 4.64. Valuation appears attractive with a forward P/E of 5.2 and a price‑to‑book of 1.19**, yet the company reports steep negative margins (gross ‑41%, operating ‑63%) and a net loss of $49.4 million for 2025, raising questions about earnings sustainability. Despite a cash pile of $51 million and zero debt, operating cash flow remains deeply negative, and the recent reduction of the quarterly dividend to $0.01 per share undermines the headline 4.73% yield.
The stock’s risk profile is elevated: a 30‑day volatility of 74% and a beta around 0.48 signal price sensitivity, while the specialty chemicals sector faces cyclical demand and regulatory headwinds in biofuels. Geographic exposure is concentrated in the United States, limiting currency risk, but modest market capitalization (~$183 million) and average trading volumes suggest medium liquidity risk. Investors should weigh the technical upside against the fundamental weakness and high volatility when forming a position.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bullish technical alignment with SMAs and MACD
  • Negative earnings and cash‑burn continue
  • Dividend cut erodes yield credibility

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Attractive forward P/E and price‑to‑book metrics
  • Potential turnaround from capital reallocation to growth projects
  • Debt‑free balance sheet provides flexibility

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • High volatility and sector cyclicality
  • Uncertain path to sustainable profitability
  • Continued exposure to biofuel policy and commodity price swings

Key Metrics & Analysis

Financial Health

Revenue Growth-67.70%
Profit Margin-51.59%
P/E Ratio5.2
ROE-27.40%
ROA-15.06%
P/B Ratio1.2
Op. Cash Flow$-28735000
Free Cash Flow$-49247376

Technical Analysis

TrendBullish
RSI57.0
Support$3.12
Resistance$4.64
MA 20$3.95
MA 50$3.89
MA 200$3.78
MACDBullish
VolumeIncreasing
Fear & Greed Index77.61

Valuation

GradeUndervalued
TypeValue
Dividend Yield4.73%

Risk Assessment

Beta0.48
Volatility74.23%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.